Follow
colm keane
colm keane
Lymphoma Research Lab, University of Queensland Diamantina Institute
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
3482015
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
F Vari, D Arpon, C Keane, MS Hertzberg, D Talaulikar, S Jain, Q Cui, ...
Blood, The Journal of the American Society of Hematology 131 (16), 1809-1819, 2018
3012018
Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma
K Jones, JP Nourse, C Keane, A Bhatnagar, MK Gandhi
Clinical cancer research 20 (1), 253-264, 2014
1562014
Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma
K Jones, F Vari, C Keane, P Crooks, JP Nourse, LA Seymour, D Gottlieb, ...
Clinical cancer research 19 (3), 731-742, 2013
1182013
Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration
JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ...
Journal of Clinical Oncology 37 (34), 3300-3309, 2019
1122019
CD4+ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy
C Keane, D Gill, F Vari, D Cross, L Griffiths, M Gandhi
American journal of hematology 88 (4), 273-276, 2013
952013
Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions
C Lees, C Keane, MK Gandhi, J Gunawardana
British journal of haematology 185 (1), 25-41, 2019
872019
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
C Keane, F Vari, M Hertzberg, KA Lê Cao, MR Green, E Han, JF Seymour, ...
The Lancet Haematology 2 (10), e445-e455, 2015
872015
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
C Keane, SC Law, C Gould, S Birch, MB Sabdia, L Merida de Long, ...
Blood Advances 4 (7), 1367-1377, 2020
832020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ...
Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021
802021
The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma
C Keane, C Gould, K Jones, D Hamm, D Talaulikar, J Ellis, F Vari, S Birch, ...
Clinical Cancer Research 23 (7), 1820-1828, 2017
802017
Stem cell–based therapies for sepsis
C Keane, M Jerkic, JG Laffey
Anesthesiology 127 (6), 1017-1034, 2017
702017
A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors
SEK Fink, MK Gandhi, JP Nourse, C Keane, K Jones, P Crooks, ...
American Journal of Transplantation 14 (11), 2577-2587, 2014
582014
EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2
AS Cristino, J Nourse, RA West, MB Sabdia, SC Law, J Gunawardana, ...
Blood, The Journal of the American Society of Hematology 134 (25), 2261-2270, 2019
552019
The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma
K Jones, L Wockner, RM Brennan, C Keane, PK Chattopadhyay, ...
Clinical & Experimental Immunology 183 (2), 206-220, 2016
552016
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
C Keane, J Tobin, J Gunawardana, S Francis, G Gifford, S Gabrielli, A Gill, ...
European journal of haematology 103 (3), 200-207, 2019
522019
Tumor‐specific but not nonspecific cell‐free circulating DNA can be used to monitor disease response in lymphoma
K Jones, JP Nourse, C Keane, P Crooks, D Gottlieb, DS Ritchie, D Gill, ...
American journal of hematology 87 (3), 258-265, 2012
412012
Homozygous FCGR3A‐158V alleles predispose to late onset neutropenia after CHOP‐R for diffuse large B‐cell lymphoma
C Keane, JP Nourse, P Crooks, D Nguyen‐Van, H Mutsando, P Mollee, ...
Internal Medicine Journal 42 (10), 1113-1119, 2012
392012
Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples
JP Nourse, P Crooks, C Keane, D Nguyen-Van, S Mujaj, N Ross, K Jones, ...
Journal of virological methods 184 (1-2), 46-54, 2012
342012
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8+ T-cell epitopes
D Nguyen-Van, C Keane, E Han, K Jones, JP Nourse, F Vari, N Ross, ...
American journal of blood research 1 (2), 146, 2011
332011
The system can't perform the operation now. Try again later.
Articles 1–20